UnitedHealth Group Stock Soars on Analyst Buy Ratings and Earnings Guidance
UnitedHealth Group stock (ISIN US91324P1021) has seen significant gains in recent days, driven by fresh analyst buy ratings and earnings guidance.
According to TipRanks, analysts have a Strong Buy consensus on the company with an average 12-month price target of USD 481.58, implying approximately 28.1 percent upside from current levels around USD 376 as of mid-September 2026.
Five-star analyst A.J. Rice of UBS reiterated his Buy rating on UnitedHealth Group and maintained a price target of USD 490 per share on September 14, 2026, citing management's confidence in sustaining mid-teens earnings per share growth.
The company's guidance for fiscal year 2026 earnings per share is set at USD 19.50 to USD 20.00, with sell-side analysts currently expecting around USD 19.82 EPS for the full year, which sits within the company's guidance range and implies mid-teens growth versus historical levels.